Anavex Life Sciences Corp (AVXL)

[Investor2014]

Conf call a bit tame as usual: no debt, 2 years of cash huge progress hope you are all mega excited, bye bye.

But the goodies were ATM not used (as I guessed wrt. outstanding share question on the MB) and won't be needed for operations, but possibly on opportunities. If I were to guess what they include, it would be A3-71 in the clinic for FTD, which has ODD and could likely attract outside funding.

How soon will near future be for quantitative updates on enrolment? My guess end Jan 50% target reached for PDD. Not sure what to guess on AD enrolment, but to be optimistic let's say 60 patients by end Jan 2019. Rett, will IMO enrol very quickly and we will likely get an update late Feb early March 2019.

New Analyst guy asked useful questions for once, the lady not so much. Good answer on where A2-73 is placed in the Parkinson's Market. Good treatments now available to control motor function, so patients gets old and hit with PDD for which there no treatments available plus A2-73 should fix up motor function too.

PDD is key to the success of A2-73 and maybe Anavex!